tradingkey.logo

Day One Says OJEMDA 2026 U.S. Net Product Revenue Projected To Be $225 - $250 Million

ReutersJan 11, 2026 10:04 PM

- Day One Biopharmaceuticals Inc DAWN.O:

  • DAY ONE ANNOUNCES PRELIMINARY 2025 OJEMDA™ NET PRODUCT REVENUE AND PROVIDES 2026 NET PRODUCT REVENUE GUIDANCE

  • DAY ONE BIOPHARMACEUTICALS INC - OJEMDA 2026 U.S. NET PRODUCT REVENUE PROJECTED TO BE $225 - $250 MILLION

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

Tradingkey
KeyAI